Factoring in Subjects Who Missed F/U | 6-Mo Occlusion Rate | Unadjusted Result | Adjusted Resulta | |||||
---|---|---|---|---|---|---|---|---|
Tubridge Group | Control Group | OR | 95% CI | P Value | OR | 95% CI | P Value | |
Missing F/U excluded (PPS) | 55/73, 75.34% | 13/53, 24.53% | 9.40 | 4.14–21.38 | <.001 | 9.31 | 4.00–21.66 | <.001 |
Missing F/U counted as complete occlusion | 64/82, 78.05% | 22/62, 35.48% | 6.47 | 3.09–13.52 | <.001 | 6.14 | 2.92–12.91 | <.001 |
Missing F/U counted as not completely occluded | 55/82, 67.07% | 13/62, 20.97% | 7.68 | 3.57–16.51 | <.001 | 7.34 | 3.36–16.05 | <.001 |
Missing F/U counted as complete occlusion for control and incomplete occlusion for Tubridge | 55/82, 67.07% | 22/62, 35.48% | 3.70 | 1.85–7.42 | <.001 | 3.49 | 1.73–7.03 | <.001 |
Note:—F/U indicates follow-up; PPS, per-protocol set.
↵a Adjusted for each subject's age and aneurysm size (≤15 versus >15 mm).